ロード中...
Bone-marrow derived mesenchymal stromal cells infusion in therapy refractory juvenile idiopathic arthritis patients
OBJECTIVES: To compare the total number of adverse events (AEs) before and after mesenchymal stromal cell (MSC) infusion in refractory JIA and to evaluate its effectiveness. METHODS: Single-centre Proof of Mechanism Phase Ib, open label intervention study in JIA patients previously failing all biolo...
保存先:
| 出版年: | Rheumatology (Oxford) |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6758577/ https://ncbi.nlm.nih.gov/pubmed/31070229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez157 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|